Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Piquet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
F1000Research|October 27, 2025
Tumor-driven stromal reprogramming in the pre-metastatic lymph nodeMichelle Piquet, David A Ruddy, Viviana Cremasco, et al.
Frontiers in Immunology|August 22, 2022
CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responsesRyan D Molony, Theresa Funk, Gina Trabucco, et al.
ACS Pharmacology & Translational Science|February 22, 2021
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance MechanismsVerena Apfel, Damien Begue, Valentina Cordo', et al.
The Journal of Clinical Investigation|June 18, 2024
Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant toleranceTakahiro Yokose, Edward S Szuter, Ivy Rosales, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Cancer Immunology Research|April 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune ResponsesRohan Diwanji, Neil A O'Brien, Jiyoung E Choi, et al.
Cancer Research|August 21, 2023
Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug ToleranceJennifer L Cotton, Javier Estrada Diez, Vivek Sagar, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
F1000Research|October 27, 2025
Tumor-driven stromal reprogramming in the pre-metastatic lymph nodeMichelle Piquet, David A Ruddy, Viviana Cremasco, et al.
Frontiers in Immunology|August 22, 2022
CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responsesRyan D Molony, Theresa Funk, Gina Trabucco, et al.
ACS Pharmacology & Translational Science|February 22, 2021
Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance MechanismsVerena Apfel, Damien Begue, Valentina Cordo', et al.
The Journal of Clinical Investigation|June 18, 2024
Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant toleranceTakahiro Yokose, Edward S Szuter, Ivy Rosales, et al.
Cancer Research|November 7, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung CancerAnirudh Prahallad, Andreas Weiss, Hans Voshol, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Cancer Immunology Research|April 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune ResponsesRohan Diwanji, Neil A O'Brien, Jiyoung E Choi, et al.
Cancer Research|August 21, 2023
Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug ToleranceJennifer L Cotton, Javier Estrada Diez, Vivek Sagar, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Pageof 2